you are viewing a single comment's thread.
"Did I hear him say equal or Better efficacy then erbitux? Bold talk."If it had exactly the same efficacy, it WOULD be better overall due to lesser side-effect profile, and lower cost per patient. He is not the first, or only, one to say this, either.
I consider that bold comment an indicator of the success of the pontine glioma and pancreatic cancer trial that we will soon get updated on. Just a guess.R
...a well-educated guess! The original 9/12 responses were impressive numbers. I hope that one child is still alive and doing well, also.